Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 143.17M
March 31, 2026 71.54M
December 31, 2025 65.93M
September 30, 2025 14.84M
June 30, 2025 32.17M
March 31, 2025 66.52M
December 31, 2024 103.66M
September 30, 2024 122.87M
June 30, 2024 99.97M
March 31, 2024 119.21M
December 31, 2023 129.57M
September 30, 2023 63.36M
June 30, 2023 92.77M
March 31, 2023 68.78M
December 31, 2022
September 30, 2022 114.71M
June 30, 2022 72.11M
Date Value
March 31, 2022 113.78M
December 31, 2021 137.70M
September 30, 2021 143.63M
June 30, 2021 172.56M
March 31, 2021 199.41M
December 31, 2020 209.52M
September 30, 2020 179.33M
June 30, 2020 194.81M
March 31, 2020 210.79M
December 31, 2019 227.23M
September 30, 2019 253.33M
June 30, 2019 204.27M
March 31, 2019 227.28M
December 31, 2018 68.08M
September 30, 2018 88.56M
June 30, 2018 102.06M
March 31, 2018 32.36M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 456.45M
UroGen Pharma Ltd. 109.30M
Ironwood Pharmaceuticals, Inc. 79.13M
Viking Therapeutics, Inc. 501.66M
IDEAYA Biosciences, Inc. 828.96M